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Abstract
Aim/hypothesis A recent genome-wide trans-ancestry meta-
analysis identified seven new loci associated with type 2
diabetes. We assessed the replication of the seven lead single
nucleotide polymorphisms (SNPs) and evaluated these loci for
additional signals in American Indians.
Methods Seven SNPs were genotyped in 7,710 individuals
from a longitudinally studied American Indian population,
and associations with type 2 diabetes, BMI and related phe-
notypes were assessed. Previous genome-wide association
study (GWAS) data from these individuals were used to
screen for additional type 2 diabetes signals at these loci. A
variant independent of the trans-ancestry meta-analysis was
identified within LPP, and its replication was assessed in an
additional 3,106 urban American Indians.
Results SNP rs6813195 near to TMEM154 was nominally
associated with type 2 diabetes ( p=0.01, OR 1.12 [95% CI
1.03, 1.22]) and adiposity: the type 2 diabetes risk allele was
associated with a lower percentage body fat (β=−1.451%, p=
4.8×10−4). Another SNP, rs3130501 near to POU5F1–
TCF19, was associated with BMI (β=−0.012, p=0.004), type
2 diabetes adjusted for BMI ( p=0.02, OR 1.11 [95% CI 1.02,
1.22]), 2 h glucose concentrations (β=0.080 mmol/l, p=0.02)
and insulin resistance estimated by homeostatic model (β=
0.039, p=0.009). The independent variant identified at the
LPP locus in our American Indian GWAS for type 2 diabetes
was replicated in the additional samples (all American Indian
meta-analysis, p=8.9×10−6, OR 1.29 [95% CI 1.15, 1.45]).
Conclusions/interpretation For two of the seven newly iden-
tified variants, there was nominal evidence for association
with type 2 diabetes and related traits in American Indians.
Identification of an independent variant at the LPP locus
suggests the existence of more than one type 2 diabetes signal
at this locus.
Keywords American Indians . ARL15 . FAF1 . GWAS .
LPP . MPHOSPH9 . POU5F1–TCF19 . SSR1–RREB1 .
Trans-ancestry meta-analysis . Type 2 diabetes
Abbreviations
GWAS Genome-wide association study
PFAT Percentage body fat
RAF Risk allele frequency
SNP Single nucleotide polymorphism
Introduction
A recent genome-wide transethnic meta-analysis which in-
cluded European, South and East Asian, Mexican, and
Mexican-American populations identified seven new type 2
diabetes susceptibility loci [1]. However, an American Indian
population was not included in this meta-analysis. Replication
of type 2 diabetes loci identified in earlier genome-wide
association studies (GWAS) was assessed in Pima Indians,
an American Indian population with a high prevalence of type
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2 diabetes, [2–4]. These loci typically had a weaker effect in
Pima Indians [2], with the exception of KCNQ1 (rs2299620),
which has a very strong effect in Pima Indians when the risk
allele is inherited maternally (p=4.1×10−12, OR 1.92 per copy
of risk allele [95% CI 1.60, 2.31]) [4]. Loci identified in a
transethnic cohort may translate across all ethnic groups to a
better extent than loci identified in a single ethnic group.
Therefore, in the current study we assessed replication in
American Indians of the seven lead single nucleotide poly-
morphisms (SNPs) identified by the transethnic meta-analysis
study on type 2 diabetes risk. We also used previous GWAS
data from Pima Indians to identify additional SNPs at these
loci associated with type 2 diabetes.
Methods
Study participants and phenotypes
Amer ican Ind ians f rom the Gi la R iver Ind ian
Community Biennial health examinations, during which
BMI was measured and diabetes status was determined using
a 75 g OGTT, were performed in a longitudinal cohort com-
prising individuals ≥5 years of age. A total of 7,710 commu-
nity members (electronic supplementary material [ESM]
Table 1) were assessed, among whom 3,625 were full-
heritage Pima and the remaining 4,085 had some degree of
American Indian heritage (on average a person’s heritage was
two-thirds American Indian). A subset of non-diabetic indi-
viduals (n=561; ESM Table 2) were also characterised in our
Clinical Research Center for percentage body fat (PFAT),
insulin sensitivity and the acute insulin response, as described
elsewhere [5, 6].
Urban American Indians An outpatient sample of urban-
dwelling American Indians living in or near to Phoenix,
Arizona (N=3,106, mean age 36.6±12.9 years, mean BMI
31.5±7.3 kg/m2), was recently recruited to a cross-sectional
study. All individuals were ≥50% American Indian, and 76%
were full-heritage Indian. Prevalence of type 2 diabetes (28%)
was determined using ADA 2010 criteria, based on measures
of fasting glucose or HbA1c or previous clinical diagnosis.
SNP selection and genotyping
SNPs identified by the transethnic meta-analysis study were
genotyped by TaqMan genotyping assays (Applied
Biosystems, Carlsbad, CA, USA). Previous GWAS data from
Pima Indians (specifically, all SNPs mapping approximately
1 Mb upstream and downstream of each lead SNP) were
evaluated to identify additional variations at any of the
transethnic meta-analysis loci that associated with type 2
diabetes in American Indians [7]. A pairwise tagging
approach using Haploview (version 4.2, Broad Institute,
Cambridge, Massachusetts, USA) identified 46 tag SNPs
(minor allele frequency >0.05 and r2≥0.8) from whole ge-
nome sequencing data of 234 Pima Indians, representing
variations 100 kb upstream and downstream of LPP
(Chr3:187,740 kb–188,808 kb). Tag SNPs were genotyped
using the BeadXpress System (Illumina, San Diego, CA,
USA). Genotype quality control required call rates of >95%,
no deviation from Hardy–Weinberg equilibrium ( p>1.0×
10−3) and a discrepancy rate of <2.5% for blind duplicates
(>100 for each sample set).
Statistical analysis
Statistical analyses were performed using SAS (version 9.2,
SAS Institute, Cary, NC, USA). Linear regression models
were used to assess the association between continuous traits
and genotypes (assuming an additive model), with adjustment
for covariates as previously described [7]. Type 2 diabetes
association results were analysed both before (N=7,710) and
after adjustment for BMI (n=6,587) using loge of the maxi-
mum recorded lifetime BMI as a covariate (Table 1). The
seven lead SNPs were previously reported to be associated
with type 2 diabetes at genome-wide significance [1]; there-
fore, in our study we considered a p value of ≤0.05 to indicate
significant replication. To assess the significance of additional
signals at each locus, a locus-specific Bonferroni-corrected p
value (0.05/number of SNPs analysed at the respective loci)
was used. The power of the current study to detect an effect
size similar to the transethnic meta-analysis was calculated
using the risk allele frequency (RAF) of the SNPs and diabetes
prevalence (34.3%) in American Indians. Results for the
rs7649407 SNP in LPP were combined in the Pima Indian
and urban American Indian samples using the inverse vari-
ance method.
Approval and consent
All studies were approved by the Institutional Review Board
of the National Institute of Diabetes and Digestive and Kidney
Diseases. Participants gave written informed consent.
Results and discussion
Association results for seven new transethnic GWASSNPs for
type 2 diabetes in 7,710 American Indians are shown in
Table 1. For comparison, data from the transethnic meta-
analysis study are also shown. The best evidence for replica-
tion was obtained for rs6813195, near TMEM154 ( p=0.01,
OR 1.12 [95% CI 1.03, 1.22]; Table 1). The direction and
effect size of the association was consistent and comparable
with that reported for individual populations within the
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transethnic meta-analysis study [1]. SNPs were also assessed
for association with BMI, and rs3130501 near POU5F1–
TCF19 had a nominal association ( p=0.004, β[loge]=
−0.012; Table 1). Analysis of type 2 diabetes association after
adjustment for BMI resulted in significant associations of both
rs6813195 and rs3130501 with type 2 diabetes (n=6,587, p=
0.007, OR 1.13 [95% CI 1.03, 1.23] and p=0.02, OR 1.11
[95% CI 1.02, 1.22], respectively; Table 1). The diabetes risk
alleles for both SNPs were associated with a lower BMI in
American Indians, as reported for some other diabetes risk
alleles in other studies [8, 9]. Three of the SNPs (rs17106184,
rs6808574 and rs702634) had a RAF of >0.96 in American
Indians; therefore, their non-significant association in the cur-
rent study may reflect a lack of power (Table 1). Of the two
SNPs with powers >70%, association of rs9505118 with type
2 diabetes was directionally consistent with the transethnic
meta-analysis study but did not reach significance ( p=0.08,
OR 1.08 [95% CI 0.99, 1.18]), while rs4275659 was not
associated with type 2 diabetes (Table 1).
Among the other traits analysed in non-diabetic individ-
uals, rs6813195 was associated with PFAT ( p=4.8×10−4,
β(%)=−1.451; ESM Table 3): the risk allele for type 2
diabetes was associated with lower body fat and lower BMI.
The type 2 diabetes risk allele of rs3130501 associated with
higher 2 h glucose concentrations during an OGTT ( p=0.02,
β=0.080 mmol/l; ESM Table 3) and insulin resistance, as
estimated by HOMA-IR (p=0.009; β=0.039; ESM
Table 3). In the subset of individuals who had undergone an
inpatient hyperinsulinaemic–euglycaemic clamp, this allele
was also associated with lower insulin sensitivity, although
not significantly ( p=0.07, β[log10]=−0.01; ESM Table 3).
Evaluation of previous Pima Indian GWAS data at each of
the seven loci identified SNPs rs7649407 and rs9882818 (r2=
1) at the LPP locus (380 SNPs analysed at the LPP locus) with
evidence of a type 2 diabetes association ( p=1×10−4). As part
of our previous GWAS follow up, rs7649407 had been geno-
typed in additional samples (N=6,834). It was among the top
signals for type 2 diabetes and also associatedwith 2 h glucose
levels following an OGTT ( p=0.007, β=0.137 mmol/l) [7].
Therefore, in the current study this locus was investigated
further by genotyping 46 tag SNPs that covered common
variation across LPP in 3,625 full-heritage Pima Indians
(ESM Table 4, Fig. 1a). In addition, 13 tag SNPs that nomi-
nally associated with type 2 diabetes or BMI were further
genotyped in the remaining 4,085 longitudinally studied
American Indians (ESM Table 4, Fig. 1a). SNPs tagged by
the GWAS SNP (rs7649407) had the strongest association
with type 2 diabetes (p=4.1×10−4, OR 1.29 [95% CI 1.12,
1.48]; Fig. 1b).
To assess the replication of this association, rs7649407 was
genotyped in an additional sample of 3,106 urban American
Indians. Among these individuals, rs7649407 had a
directionally consistent association with type 2 diabetes ( p=
0.007, OR 1.31 [95% CI 1.08, 1.59]; Fig. 1b), and a meta-
analysis combining the two samples showed a stronger asso-

















































































nAA 2,529 1,526 1,541 1,106 852
nAG 781 529 494 374 284
nGG 76 39 42 30 22
Fig. 1 Association of rs7649407 in LPP with type 2 diabetes (T2D) in
American Indians from the Gila River Indian Community, and replication
in cross-sectionally studied urban American Indians. (a) Associations of
46 tag SNPs across the region (Chr3:187,740 kb–188,808 kb)
encompassing LPP with T2D in American Indians. Results were
analysed in full-heritage Pima Indians (diamonds; N=3,625), all Ameri-
can Indians from the Gila River Indian community including full-heritage
Pima Indians (triangles; N=7,710) and combined American Indians and
urban American Indians (squares; N=10,816); p values were adjusted for
age, sex, birth year, family membership and admixture estimates. (b) T2D
prevalence in American Indians from the Gila River Indian Community
(p=4.1×10−4, OR 1.29 [1.12, 1.48]) and urban American Indians (p=
0.007, OR 1.31 [1.08, 1.59]) by LPP SNP rs7649407 (A/G) genotype. All
American Indian meta-analysis: p=8.9×10–6, OR 1.29 [95% CI 1.15,
1.45]. ORs and p values were adjusted for age, sex, birth year, family
membership and admixture estimates. Black bars, GG genotype; grey
bars, AG genotype; white bars, AA genotype. (c) T2D prevalence in
different age groups by LPP SNP rs7649407 genotype. Triangles, GG
genotype; squares, AG genotype; diamonds, AA genotype
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Fig. 1a, b). The association was consistent across all age
groups (Fig. 1c). This SNP (rs7649407) exhibits low linkage
disequilibrium with rs6808574 (near to LPP), which was
reported in the transethnic meta-analysis study (D′=0.14,
r2=0 in Pima Indians; D′=0.08, r2=0 in Utah residents with
ancestry from northern and western Europe (CEU); HapMap
V3, R2, http://hapmap.ncbi.nlm.nih.gov/). In American
Indians, the association of rs7649407 was unaffected by a
conditional analysis with rs6808574. Therefore, we propose
that the LPP locus may contain more than one region of
association with type 2 diabetes. It is noteworthy that
rs7649407, with a RAF of 0.88 in the present study, has a
RAF of 0.99 in some Asian populations and may therefore not
be informative in these populations. ENCODE data shows that
rs7649407 maps to an intronic region with a strong enhancer
effect in multiple cell types, including skeletal muscle
myoblasts [10]. However, we did not find a clear relationship
between rs7649407 genotype and LPP expression in 250
skeletal muscle biopsies from Pima Indians (data not shown).
The role of the encoded protein, lipoma-preferred partner
(LPP), in the regulation of glucose metabolism is unknown
and will require further investigations.
In conclusion, analysis of type 2 diabetes SNPs initially
reported in a transethnic meta-analysis identified nominal
replication of two SNPs (rs6813195 and rs3130501) in
Americans Indians. Analysis of the implicated loci in this
population of non-European ancestry identified an indepen-
dent LPP variant that reproducibly associated with type 2
diabetes in American Indians, thus demonstrating the utility
of including populations of diverse ‘nonstandard’ ancestry in
the identification of susceptibility loci.
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